may 2001 OITN - 11

a   e_r
from here:

CiE,PTHea”riy',onv|ea\'(es yvourwith choices
t for later. Ask your d‘o:c”tor,about
with V1RAC,EPT. f ‘ ‘

. : \  -T®
nuelfinavirirniesvylate

tablets and oral powder

ect of,VlRACEPT, is diarrhea, which 
aiiy be controlled with over—the—
treatments. Some prescription
‘n-prescription" _c£m.g's and sup-
A snts should n_ot,be%taken with .
CEPT, so  taikto your doctor first.
orifae" eopilcei, protease, inhibitors
een; associated'vvith the onset
rsen rig of .diabetes‘ m'.e~Hit_us~
yfpergiycemia,chang'eis in ‘ '
y fat, and-increased b|'eedin'_g
’mo'phi.li_acs. ' 

 

i

RACEPT and Agouron are registered trademarks of Agou ‘idri Pharmaceuticals, Inc.
Copyright ‘C 20 1, Agouron Pharmaceutica|s,Inc. All rights reserved. V01l36»CC